Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine During Surgery in Operable Breast Cancer
NCT01916317Phase 3Active, not recruiting
- Sponsor
- Tata Memorial Hospital
- Start
- Dec 2011
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in breast cancer, sponsored by Tata Memorial Hospital. Started Dec 2011; status: active, not recruiting.
02
Drugs
lidocaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01916317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916317.